Clinical Trials

    Showing 1 - 4 of 4 Nutritional and Metabolic Conditions %26 Diseases

    A Multicenter, Randomized, Double-blind, Sham-controlled study for Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals with Type II Diabetes

    Status: Enrolling

    Investigator: Abhishek Kansara

    Study Coordinator: Steven Puckitt

    Phone: 346.238.4586

    This research study is designed to evaluate the safety and effectiveness of the ReCET™ device for improving glycemic (blood sugar) control in individuals with T2D. This study plans to enroll a minimum of 264 and a maximum of 350 participants from ... Read more >

    A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events (TRANSFORM)

    Status: Enrolling

    Investigator: Sadeer Al-Kindi

    Study Coordinator: Peyton Martin

    Phone: 346.356.3691

    TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease. The trial tests the h... Read more >

    Association of Plaque Burden and Morphology on Coronary CT Angiography with Proteomic Profiling and Genome-wide Genotyping in South Asians living in the US

    Status: Enrolling

    Investigator: Waleed Ahmed

    Study Coordinator:

    Phone:

    This study is a prospective, observational case control study that will generate preliminary data from 50 cases (South Asian) and 100 controls (50 South Asian and 50 non-South Asian) who have undergone clinically indicated CTAs. Participants will be ... Read more >

    DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLOZASIRAN IN ADULTS WITH SEVERE HYPERTRIGLYCERIDEMIA (SHASTA-3 STUDY)

    Status: Open Not Enrolling

    Investigator: Abhishek Kansara

    Study Coordinator: Steven Puckitt

    Phone: 346.238.4586

    This is a multi-center, randomized, double-blind, placebo-controlled Phase 3 study to evaluate the efficacy and safety of plozasiran injection in approximately 1328 adult subjects with HTG. After informed consent, subjects will be assessed for eligib... Read more >